SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-15-052655
Filing Date
2015-06-12
Accepted
2015-06-12 13:19:52
Documents
1
Period of Report
2015-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4475
  Complete submission text file 0001209191-15-052655.txt   5940
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1415 LOUISIANA STREET, SUITE 2700 HOUSTON TX 77002
Business Address
Giroir L. Patrick Jr. (Reporting) CIK: 0001436264 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35837 | Film No.: 15927956